Compare AbCellera Biologics Inc (ABCL) vs Global X Copper Miners ETF (COPX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Global X Copper Miners ETF — how do they compare? AbCellera Biologics Inc trades at $7.15 (market cap $2.35B), while Global X Copper Miners ETF trades at $72.69. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, Global X Copper Miners ETF nearer its low. Which is the better fit depends on your goals.
| ABCL | COPX | |
|---|---|---|
Market Cap | $2.35B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $8.12 | $95.70 |
52-Week Low | $2.78 | $42.75 |
Enterprise Value | $1.99B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
COPX (Global X Copper Miners ETF) trades at $78.48, up 2.39% with a bullish technical signal despite mixed moving averages. The ETF provides diversified exposure to copper mining companies benefiting from AI-driven copper demand growth. Recent news highlights copper's structural deficit and AI infrastructure needs as key catalysts. Technical indicators show RSI_12 at 24.51 (buy signal) while ADX suggests strong trend momentum.
Outlook remains positive given copper's essential role in AI infrastructure and electrification trends. Key risks include copper price volatility and supply chain constraints. The ETF offers leveraged exposure to copper prices through mining equities, with support at $76 and resistance at $79-80 levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Global X Copper Miners ETF
COPX tracks the Solactive Global Copper Miners Total Return Index, providing broad exposure to companies worldwide involved in copper mining, refining, and exploration. It serves as an equity-based alternative to copper futures, offering a leveraged play on copper demand driven by global infrastructure and the clean energy transition.
Read more on COPX →
